Nghĩa của từ glutamic acid bằng Tiếng Hungari
glutaminsav
Đặt câu có từ "glutamic acid"
1. All phenylketonurics had elevated concentrations of glutamic acid.
2. MSG is one of several forms of glutamic acid found in foods, in large part because glutamic acid (an amino acid) is pervasive in nature.
3. Oxygen-function amino-compounds, except lysine and glutamic acid
4. Positive test for glutamic acid by thin layer chromatography
5. Reaction products of: glutamic acid and N-(C#-alkyl)propylenediamine
6. Reaction products of: glutamic acid and N-(C12-14-alkyl) propylenediamine
7. Reaction products of: glutamic acid and N-(C12-14-alkyl)propylenediamine
8. CPA 20.14.42: Oxygen-function amino-compounds, except lysine and glutamic acid
9. Reaction products of: glutamic acid and N-(C12-C14-alkyl)propylenediamine (Glucoprotamin)
10. The enzyme that carries out the carboxylation of glutamic acid is gamma-glutamyl carboxylase.
11. Mucus layer-adhesive poly γ-glutamic acid nanomicelles and drug delivery system using same
12. The term 'natural flavor' is now used by the food industry when using glutamic acid.
13. In the fasting plasma of heterozygotes glutamic acid, phenylalanine and tyrosine are elevated with only minor significance.
14. Poly (γ-glutamic acid) (PGA) is water-soluble, anionic, biodegradable, and edible Biopolymer produced by Bacillus subtilis
15. The nonessential amino Acids are glycine, arginine, alanine, asparagine, cysteine, aspartic acid, glutamic acid, glutamine, proline, serine and tyrosine
16. The present invention provides a series of processes for preparing 2-pyrrolidone from glutamic acid or glutamate using biomass.
17. In addition, 1,8 moles of ammonia were found per mole of glutamic acid, indicating, that both DAP and Glu are present as amides.
18. The use of MSG as a food additive and the natural level of glutamic acid in foods are not toxicological concerns in humans.
19. Find patient medical information for glutamic acid-Betain-methylcel oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
20. The present invention relates to a method for producing γ-aminobutyric acid (GABA) by a biotransformation process using glutamate or glutamic acid as a substrate.
21. Pidolic acid is an endogenous amino acid derivative where the free amino group of glutamic acid or glutamine Cyclizes to generate a lactam [A32991, L2729]
22. IA-2 Antibody, Panel,Diabetes Antibody Panel,Glutamic Acid Decarboxylase-65 Antibody Panel,Insulin Autoantibody, Panel LOINC® Codes, Performing Laboratory Service Area must be determined
23. Composition and food product comprising green tea extract containing catechin gallate and poly-gamma-glutamic acid for inhibiting alcohol absorption or inhibiting liver damage from alcohol
24. The present invention relates to a composition or a food product containing catechin gallate and poly-gamma-glutamic acid for inhibiting alcohol absorption and/or liver damage from alcohol.
25. The pH level of the composite of L-glutamic acid and basic amino acids is finely adjusted to a predetermined range, thereby providing a complex amino acid seasoning having superior pleasantness.
26. Along with glutamic acid and glycine, Cysteine is a key constituent of glutathione, a potent antioxidant that is found in all human tissues with the highest concentrations being found in the liver and eyes.
27. The present invention relates to an amino acid seasoning composition which comprises L-glutamic acid and basic amino acids, and which has a pH level of 6.5 to 8.0 when in the form of an aqueous solution.
28. Light accelerates the genesis of the amino-acids which can derivate from initial products of photosynthesis (alanine, serine, glycine) as well as from amino-acids, the carbon chains of which proceed from a second carboxylation (aspartic acid and alanine) or from cellular oxydations (glutamic acid, aminobutyric acid).
29. Antigen-directed therapy and treatment with islet antigens, such as glutamic acid decarboxylase (GAD) or heat shock protein 60 peptide (DiaPep277), as well as anti-inflammatory treatment with atorvastatin, interleukin 1 receptor antagonist (IL1RA) or immune cell directed treatment (anti-CD3, anti-CD20, abatacept) are currently under investigation.
30. Bioph):tics, University of Washington School of Medicine, Seattle, WA (U.S.A.) (Received 3 May, 1984) (Revised, received 2 July, 1984) (Accepted 3 July, 1984) SUMMARY The toxicity of L-glutamic acid toward cultured fibroblasts and lymphocytes from age-matched, sex-matched controls, patients with Huntington's disease (HD) and
31. Chronic undercutting of cerebral cortex in the cat for survival periods of 9 to 308 days was found to cause an increase in duration of epileptiform electrical, afterdischarge and a significant decrease in content of glutamic acid, GABA, and aspartic acid as compared with homologous cortex of opposite hemisphere.
32. According to the present invention, when the nanomicelles drug delivery system on the basis of the poly γ-glutamic acid, which is a biogenous natural polymer, is utilized in the field of drug delivery to a mucus layer region, the nanomicelles drug delivery system can improve biostability and effectiveness of a drug.
33. The invention relates to food additives containing (a) glutamic acid and (b) at least one nucleotide or the alkali salts and/or alkaline-earth salts thereof and optionally (c) flavourings selected from the group formed by purines, polyphenols, 2-acetyl pyrazine, 3-methylbutanol, 2-phenyl ethyl acetate, trimethylpyrazine and mixtures thereof (d) salt, (e) sweeteners and/or (f) acidulants.
34. The present invention relates to an antigenic polypeptide sequence of factor VIII, comprised between the Glutamic Acid 1649 and Asparagine 2019, preferably comprised between Arginine 1652 and Arginine 1917 of the polypeptide sequence of factor VIII, or comprised between Alanine 108 and Methionine 355, or comprised between Aspartic Acid 403 and Aspartic Acid 725, or comprised between Lysine 2085 and Lysine 2249.
35. (2) Commission Implementing Regulation (EU) 2018/249 of 15 February 2018 concerning the authorisation of taurine, beta-alanine, L-alanine, L-arginine, L-aspartic acid, L-histidine, D,L-isoleucine, L-leucine, L-phenylalanine, L-proline, D,L-serine, L-tyrosine, L-methionine, L-valine, L-cysteine, glycine, monosodium glutamate and L-glutamic acid as feed additives for all animal species and L-cysteine hydrochloride monohydrate for all species except cats and dogs (OJ L 53, 23.2.2018, p.
36. is the residue of an $g(a)-amino acid selected from the group consisting of alanine (Ala), arginine (Arg), aspartic acid (Asp), glutamic acid (Glu), histidine (His), homophenylalanine (HPhe), phenylalanine (Phe), ornithine (Orn), serine (Ser) and threonine (Thr), and substituted analogues thereof; X is a fluorine-free leaving group selected from the group consisting of phenoxy, substituted phenoxy and heterophenoxy; E and G are one or more atoms more electronegative than carbon; and D is hydrogen, methyl or a substituted methyl.
37. Formulations comprising (A) at least one aminocarboxylate selected from methylglycine diacetate (MGDA), iminodisuccinic acid (IDS) and glutamic acid diacetate (GLDA) and salts and derivatives thereof, and (B) at least one alkoxylated alkyleneimine polymer having a mean molecular weight Mw in the range from 800 to 25 000 g/mol, which has a positive charge density of at least 5 meq/g and which has in the range from 2 to not more than 80% by weight of alkylene oxide side chains, based on overall alkoxylated alkyleneimine polymer.
38. The present invention provides an eperisone pharmaceutical composition having improved preservability and pH stability, the composition containing 20-60 wt% of eperisone or a pharmaceutically acceptable salt thereof; 1-30 wt% of at least one acidifier selected from D-glucaric acid, D-glucoascorbic acid, gluconic acid, D-glucuronic acid, gluconolactone, glucuronolactone, glutamic acid, itaconic acid, caffeic acid, glycyrrhizic acid, ethane sulfonic acid, benzene sulfonic acid, dehydroascoribic acid, salicylic acid, salicyl sulfonic acid, gallic acid, nicotinic acid, and chlorogenic acid; 0.3-8 wt% of a binder; and 10-80 wt% of a diluent.